News
Mia.Sawyer@easyfairs.com

Ameela releases PDRN masks

Medical aesthetic company Ameela has debuted its Wild Salmon PDRN Mask, designed as a bioactive post-procedure sheet mask for in-clinic use. Available through aesthetic distributor Amedica, Ameela shares that the

Read More »
News
Mia.Sawyer@easyfairs.com

Healthxchange introduces Potenza

Aesthetics attended aesthetic distributor Healthxchange’s official UK&I launch of Potenza at Bacchanalia in Mayfair. The evening featured Potenza key opinion leaders international dermatologist Dr Íñigo de Felipe and aesthetic practitioner

Read More »
News
Mia.Sawyer@easyfairs.com

ACRE announces new partnerships

Aesthetic distributor ACRE has revealed distribution partnerships with pharmaceutical company IBSA Derma and skincare brand ZO Skin Health. IBSA Derma shares that ACRE’s pharmaceutical expertise, trusted service model and deep

Read More »
News
Mia.Sawyer@easyfairs.com

Twiqk hosts inaugural event

Verification and consumer education platform Twiqk welcomed specialty guests to its inaugural Twiqk Preview event at Stationers’ Hall in London. Sponsored by Japanese wellness brand Yotsuba, the event featured panel

Read More »
News
Mia.Sawyer@easyfairs.com

PRP Pure unveils two new injectables

Platelet-rich plasma (PRP) training provider PRP Pure has announced two new injectables to officially launch at the Clinical Cosmetic Regenerative Congress (CCR) 2026. The first launch taking place is EXOBIOFILLER,

Read More »
News
Mia.Sawyer@easyfairs.com

BCAM issues warning over hay fever relief

The British College of Aesthetic Medicine (BCAM) has urged patients to prioritise safety when considering steroid injections for hay fever relief. BCAM shares that, following reports of growing popularity, some

Read More »
News
Mia.Sawyer@easyfairs.com

Aesthetics attends SkinCeuticals breakfast

Skincare company SkinCeuticals hosted press and practitioners to present its newly launched P-TIOX Cream and the next generation of PHYTO CORRECTIVE on July 14. The morning opened with David McNulty-Ringshaw,

Read More »
News
Mia.Sawyer@easyfairs.com

Emerging antibody-based treatment for AGA

Biotechnology company Absci has released positive interim Phase 1 data from its first-in-human trial of investigational anti-prolactin receptor (PRLR) antibody ABS-201. The company details that ABS-201 is an experimental antibody

Read More »